Belite Bio Current Ratio vs. Total Debt

BLTE Stock  USD 66.99  1.99  3.06%   
Considering Belite Bio's profitability and operating efficiency indicators, Belite Bio ADR may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Belite Bio's ability to earn profits and add value for shareholders.
 
Current Ratio  
First Reported
2010-12-31
Previous Quarter
24.75639967
Current Value
16.43
Quarterly Volatility
4.7240388
 
Credit Downgrade
 
Yuan Drop
 
Covid
At present, Belite Bio's Book Value Per Share is projected to increase slightly based on the last few years of reporting. The current year's PB Ratio is expected to grow to 14.13, whereas Operating Cash Flow Per Share is forecasted to decline to (1.18).
For Belite Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Belite Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Belite Bio ADR utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Belite Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Belite Bio ADR over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Belite Bio. If investors know Belite will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Belite Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.13)
Return On Assets
(0.26)
Return On Equity
(0.40)
The market value of Belite Bio ADR is measured differently than its book value, which is the value of Belite that is recorded on the company's balance sheet. Investors also form their own opinion of Belite Bio's value that differs from its market value or its book value, called intrinsic value, which is Belite Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Belite Bio's market value can be influenced by many factors that don't directly affect Belite Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Belite Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Belite Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Belite Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Belite Bio ADR Total Debt vs. Current Ratio Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Belite Bio's current stock value. Our valuation model uses many indicators to compare Belite Bio value to that of its competitors to determine the firm's financial worth.
Belite Bio ADR is rated second in current ratio category among its peers. It is rated below average in total debt category among its peers making up about  25,307  of Total Debt per Current Ratio. At present, Belite Bio's Current Ratio is projected to drop based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Belite Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Belite Total Debt vs. Current Ratio

Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Belite Bio

Current Ratio

 = 

Current Asset

Current Liabilities

 = 
35.01 X
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Belite Bio

Total Debt

 = 

Bonds

+

Notes

 = 
886 K
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

Belite Total Debt vs Competition

Belite Bio ADR is rated below average in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 371.6 Million. Belite Bio adds roughly 886,000 in total debt claiming only tiny portion of equities under Health Care industry.
Total debt  Revenue  Workforce  Capitalization  Valuation

Belite Bio Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Belite Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Belite Bio will eventually generate negative long term returns. The profitability progress is the general direction of Belite Bio's change in net profit over the period of time. It can combine multiple indicators of Belite Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-374 K-392.7 K
Net Interest Income49 K51.5 K
Interest Income74 K77.7 K
Operating Income-31.7 M-30.1 M
Net Loss-31.6 M-30.1 M
Income Before Tax-31.6 M-30 M
Total Other Income Expense Net45 K42.8 K
Net Loss-8.7 M-9.1 M
Net Loss-31.6 M-30.1 M
Income Tax ExpenseK9.4 K
Change To Netincome1.8 M1.6 M
Net Loss(1.19)(1.25)
Income Quality 0.94  0.68 
Net Income Per E B T 1.00  1.10 

Belite Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Belite Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Belite Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Belite Bio's important profitability drivers and their relationship over time.

Use Belite Bio in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Belite Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Belite Bio will appreciate offsetting losses from the drop in the long position's value.

Belite Bio Pair Trading

Belite Bio ADR Pair Trading Analysis

The ability to find closely correlated positions to Belite Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Belite Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Belite Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Belite Bio ADR to buy it.
The correlation of Belite Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Belite Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Belite Bio ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Belite Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Belite Bio position

In addition to having Belite Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Marijuana Thematic Idea Now

Marijuana
Marijuana Theme
Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States. The Marijuana theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marijuana Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Belite Bio ADR is a strong investment it is important to analyze Belite Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Belite Bio's future performance. For an informed investment choice regarding Belite Stock, refer to the following important reports:
Check out Trending Equities.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
To fully project Belite Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Belite Bio ADR at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Belite Bio's income statement, its balance sheet, and the statement of cash flows.
Potential Belite Bio investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Belite Bio investors may work on each financial statement separately, they are all related. The changes in Belite Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Belite Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.